NPY and Y receptors: Lessons from transgenic and knockout models

Neuropeptides

Volumn 38, Issue 4, 2004, Pages 189-200

  Lin, Shu ^a   Boey, Dana ^a   Herzog, Herbert ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y3 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NEUROPEPTIDE Y6 RECEPTOR; PANCREAS POLYPEPTIDE; PEPTIDE YY; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; AMINO ACID SEQUENCE; AMYGDALOID NUCLEUS; BLOOD PRESSURE REGULATION; BODY WEIGHT; BONE MASS; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; ENDOCRINE FUNCTION; FERTILITY; FOOD INTAKE; FOREBRAIN; GENE DELETION; GENETIC CODE; GLUCOSE UTILIZATION; HEART RATE; HIPPOCAMPUS; HORMONE RELEASE; HYPERALGESIA; HYPOTHALAMUS; IMMUNOREACTIVITY; KNOCKOUT MOUSE; LIGHT DARK CYCLE; LOCOMOTION; MAZE TEST; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSSIFICATION; PEPTIDE ANALYSIS; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SEIZURE SUSCEPTIBILITY; SIGNAL TRANSDUCTION; SPECIES COMPARISON; START CODON; TISSUE DISTRIBUTION; TRANQUILIZING ACTIVITY; TRANSGENIC ANIMAL; VAGOTOMY; WEIGHT GAIN; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; HOMEOSTASIS; MICE; MICE, KNOCKOUT; NEUROPEPTIDE Y; PHENOTYPE; RATS; RECEPTORS, NEUROPEPTIDE Y;

EID: 4444256688     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2004.05.005     Document Type: Review

References (56)

1. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Ghomas G.P., Gardiner E.M., Herzog H. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Invest. 109:2002;915-921
2. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., McCaleb M.L. Behavioral characterization of neuropeptide Y knockout mice. Brain Res. 868:2000;79-87
3. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17(23):1997;8927-8936
4. Baskin D.G., Breininger J.F., Schwartz M.W. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes. 48:1999;828-833
5. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., et al. Gut hormone PYY3-36 physiologically inhibits food intake. Nature. 418:2002;650-654
6. Blomqvist A.G., Herzog H. Y-receptor subtypes-how many more? Trends Neurosci. 20:1997;294-298
7. Broberger C., Landry M., Wong H., Walsh J.N., Hokfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology. 66:1997;393-408
8. Burcelin R., Brunner H., Seydoux J., Thorensa B., T. P. Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice. Peptides. 22:2001;421-427
9. Chu D.Q., Cox H.M., Costa S.K., Herzog H., Brain S.D. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors. Br. J. Pharmacol. 140:2003;422-430
10. Couzens M., Liu M., Tuchler C., Kofler B., Nessler-Menardi C., Parker R.M.C., Klocker H., Herzog H. Peptide YY-2 (PYY2) and pancreatic polypeptide-2 (PPY2): species specific evolution of novel members of the neuropeptide Y gene family. Genomics. 64:2000;318-323
11. Ekstrand A.J., Cao R., Bjorndahl M., Nystrom S., Jonsson-Rylander A.C., Hassani H., Hallberg B., Nordlander M., Cao Y. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc. Natl. Acad. Sci. USA. 100:2003;6033-6038
12. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-418
13. Erickson J.C., Hollopeter G., Palmiter R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274:1996;1704-1707
14. Erickson J.C., Ahima R.S., Hollopeter G., Flier J.S., Palmiter R.D. Endocrine function of neuropeptide Y knockout mice. Regul. Pept. 70(2-3):1997;199-202
15. Guo H., Castro P.A., Palmiter R.D., Baraban S.C. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus. J. Neurophysiol. 87:2002;558-566
16. Hansel D.E., Eipper B.A., Ronnett G.V. Neuropeptide Y functions as a neuroproliferative factor. Nature. 410:2001;940-944
17. Hazelwood R.J. The Pancreatic Polypeptide (PP-fold) Family: Gastrointestinal, Vascular, and Feeding Behavioral Implications. Exp. Biol. Med. 202:1993;44-63
18. Hohmann J.G., Teklemichael N.D., Weinshenker D., Wynick D., Clifton D.K., Steiner R.A. Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin. Mol. Cell. Biol. 2004;2978-2985
19. Hokfelt T., Broberger C., Zhang X., Diez M., Kopp J., Xu Z., Landry M., Bao L., Schalling M., Koistinaho J., et al. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res. Brain Res. Rev. 26:1998;154-166
20. Hollopeter G., Erickson J.C., Palmiter R.D. Role of neuropeptide Y in diet-, chemical- and genetic-induced obesity of mice. Int. J. Obesity. 22:1998;506-512
21. Howell O.W., Scharfman H.E., Beck-Sickinger A.G., Herzog H., Gray W.P. Neuropeptide Y is neuroproliferative in primary hippocampal cultures. J. Neurochem. 86:2003;646-659
22. Inui A., Okita M., Nakajima M., Momose K., Ueno N., Teranishi A., Miura M., Hirosue Y., Sano K., Sato M., et al. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. Proc. Assn. Am. Physicianc. 110:1998;171-182
23. Kaga T., Inui A., Okita M., Asakawa A., Ueno N., Kasuga M., Fujimiya M., Nishimura N., Dobashi R., Morimoto Y., et al. Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding. Diabetes. 50:2001;1206-1210
24. Kanatani A., Mashiko S., Murai N., Sugimoto N., Ito J., Fukuroda T., Fukami T., Morin N., MacNeil D.J., Van der Ploeg L.H.T., et al. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology. 141:2000;1011-1016
25. King P.J., Williams G., Doods H., Widdowson P.S. Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release. Eur. J. Pharmacol. 396:2000;R1-R3
26. Kushi A., Sasai H., Koizumi H., Takeda N., Yokoyama M., Nakamura M. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc. Natl. Acad. Sci. USA. 95:1998;15659-15664
27. Lee E.W., Grant D.S., Movafagh S., Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides. 24:2003;1-177
28. Marsh D.J., Hollopeter G., Kafer K.E., Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat. Med. 4:1998;718-721
29. Marsh D.J., Baraban S.C., Hollopeter G., Palmiter R.D. Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc. Natl. Acad. Sci. USA. 96:1999;13518-13523
30. Michalkiewicz M., Michalkiewicz T. Developing transgenic neuropeptide Y rats. Meth. Mol. Biol. 153:2000;73-89
31. Michalkiewicz M., Michalkiewicz T., Kreulen D.L., McDougall S.J. Increased blood pressure responses in neuropeptide Y transgenic rats. Am. J. Physiol. - Regul. Integrative Comp. Physiol. 281:2001;R417-426
32. Naveilhan P., Neveu I., Arenas E., Ernfors P. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience. 87:1998;289-302
33. Naveilhan P., Hassani H., Canals J.M., Ekstrand A.J., Larefalk A., Chhajlani V., Arenas E., Gedda K., Svensson L., Thoren P., et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat. Med. 5:1999;1188-1193
34. Naveilhan P., Canals J., Valjakka A., Vartiainen J., Arenas E., Ernfors P. Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism. Eur. J. Neurosci. 13:2001;2241-2246
35. Naveilhan P., Canals J.M., Arenas E., Ernfors P. Distinct roles of the Y1 and Y2 receptors on neuropeptide Y-induced sensitization to sedation. J. Neurochem. 78:2001;1201-1207
36. Naveilhan P., Hassani H., Lucas G., Blakeman K.H., Hao J.X., Xu X.J., Wiesenfeld-Hallin Z., Thoren P., Ernfors P. Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature. 409:2001;513-517
37. Naveilhan P., Svensson L., Nystrom S., Ekstrand A.J., Ernfors P. Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation. Peptides. 23:2002;1087-1091
38. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11:1999;1431-1448
39. Pedrazzini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., Brunner H.R. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat. Med. 4:1998;722-726
40. Pralong F.P., Gonzales C., Voirol M.J., Palmiter R.D., Brunner H.R., Gaillard R.C., Seydoux J., Pedrazzini T. The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J. 16:2002;712-714
41. Qian S., Chen H., Weingarth D., Trumbauer M.E., Novi D.E., Guan X., Yu H., Shen Z., Feng Y., Frazier E., et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell. Biol. 22:2002;5027-5035
42. Redrobe J.P., Dumont Y., Herzog H., Quirion R. Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: Evidence from Y2 receptor knockout mice. Behav. Brain Res. 141(2):2003;251-255
43. Sainsbury A., Schwarzer C., Couzens M., Fitissov S., Furtinger S., Jenkins A., Cox H.M., Sperk G., Hokfelt T., Herzog H. Important role of hypothalamic Y2 receptors in bodyweight regulation revealed in conditional knockout mice. Proc. Natl. Acad. Sci. USA. 99:2002;8938-8943
44. Sainsbury A., Schwarzer C., Couzens M., Herzog H. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes. 51:2002;3420-3427
45. Sainsbury A., Schwarzer C., Couzens M., Jenkins A., Oakes S.R., Ormandy C.J., Herzog H. Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev. 16:2002;1077-1088
46. Sainsbury A., Baldock P.A., Schwarzer C., Ueno N., Enriquez R.F., Couzens M., Inui A., Herzog H., Gardiner E.M. Synergistic reduction in adiposity and increase in bone mass in Y2/Y4 receptor double knockout mice. Mol. Cell. Biol. 23:2003;5225-5233
47. Schenk F., Baron U., Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:1995;5080-5081
48. Shi T., Zhang X., Berge O., Erickson J., Palmiter R., Hokfelt T. Effect of peripheral axotomy on dorsal root ganglion neuron phenotype and autonomy behaviour in neuropeptide Y-deficient mice. Regul. Pept. 75-76:1998;161-173
49. Smith-White M., Herzog H., Potter E. Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission. Regul. Pept. 103:2002;105-111
50. Smith-White M.A., Herzog H., Potter E.K. Cardiac function in neuropeptide Y Y4 receptor-knockout mice. Regul. Pept. 110:2002;47-54
51. Thiele T., Marsh D., Ste Marie L., Bernstein I., Palmiter R. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature. 396:1998;366-369
52. Thiele T., Koh M., Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 22:2002;208-212
53. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., Mathe A., Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl. Acad. Sci. USA. 97:2000;12852-12857
54. Tschenett A., Singewald N., Carli M., Balducci C., Salchner P., Vezzani A., Herzog H., Sperk G. Reduced anxiety and improved stress coping ability in mice lacking neuropeptide Y-Y2 receptors. Eur. J. Neurosci. 18:2003;143-148
55. Ueno N., Inui A., Iwamoto M., Kaga T., Asakawa A., Okita M., Fujimiya M., Nakajima Y., Ohmoto Y., Ohnaka M., et al. Decreased food intake and body weight in pancreatic polypeptide- overexpressing mice. Gastroenterology. 117:1999;1427-1432
56. Vezzani A., Michalkiewicz M., Michalkiewicz T., Moneta D., Ravizza T., Richichi C., Aliprandi M., Mule F., Pirona L., Gobbi M., et al. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience. 110:2002;237-243